| Drug Name | ( Genvoya ®(Emtricitabine, Elvitegravir , Cobicistat ,Tenofovir, Alafenamide |
|---|---|
| المجموعة الدوائية |
Anti-viral
|
| نوع وسيلة تقليل المخاطر |
رسالة موجهه للممارسين الصحيين
|
| Specialty (Theraputic area) |
Infectious disease
|
| المخاطر |
Increased risk of treatment failure and increased risk of mother-to-child transmission of HIV infection due to lower exposure of elvitegravir and cobicistat during the second and third trimesters of pregnancy |
| رسالة موجهه للممارسين الصحيين |
|